New dialysis method with once-daily special fluid
Part of Kidney & urinary clinical trials.
This trial studies a type of peritoneal dialysis using a special fluid called icodextrin once a day. It may help people who still make a good amount of urine to remove extra fluid more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have chronic kidney disease stage 5 and are about to start peritoneal dialysis
- Your remaining kidney function (eGFR) is at least 5
- You still make 800 ml or more of urine each day
- You have not had a severe allergic reaction to icodextrin or standard dialysis fluid
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special dialysis fluid called icodextrin can help people on a low-dose form of peritoneal dialysis stay on that low dose longer before needing a full dose. It is for adults who still make some urine and can do dialysis at home.
This trial studies how much of a dialysis fluid called icodextrin stays in your body after one or two doses. It is for people on long-term peritoneal dialysis who are stable and can follow a specific daily schedule.
This trial compares using two doses of icodextrin (a dialysis solution) instead of one to see if it improves fluid balance and blood pressure in children on peritoneal dialysis. It may help those with high blood pressure and low urine output.
This Phase 3 trial studies how well a new peritoneal dialysis solution works and whether it is safe. It’s meant for adults with kidney failure who already do a specific type of at-home dialysis.
This study tests how well a continuous glucose monitor (CGM) works in people with diabetes who are also using a special dialysis fluid called icodextrin. The goal is to see if the CGM gives accurate readings while on this treatment.
This trial tests if canagliflozin, a diabetes medicine, helps remove extra fluid and reduce scarring in people on peritoneal dialysis (home-based dialysis). It may improve your dialysis results and protect your belly lining.
Hear when a new Peritoneal Dialysis Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.